Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program

Rafeek A Yusuf; Jaime M Preussler; Christa L Meyer; Katie Schoeppner; Jennifer A Sees Coles; Amber Ruffin; Meggan McCann; Steven M Devine; Jeffery J Auletta

doi:10.1016/j.beha.2023.101480

Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program

Best Pract Res Clin Haematol. 2023 Jun;36(2):101480. doi: 10.1016/j.beha.2023.101480. Epub 2023 May 25.

Authors

Rafeek A Yusuf¹, Jaime M Preussler², Christa L Meyer³, Katie Schoeppner⁴, Jennifer A Sees Coles⁵, Amber Ruffin⁶, Meggan McCann⁷, Steven M Devine⁸, Jeffery J Auletta⁹

Affiliations

¹ National Marrow Donor Program, Minneapolis, MN, USA; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA. Electronic address: ryusuf@nmdp.org.
² National Marrow Donor Program, Minneapolis, MN, USA; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA. Electronic address: jpreussl@nmdp.org.
³ National Marrow Donor Program, Minneapolis, MN, USA; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA. Electronic address: cmeyer@nmdp.org.
⁴ National Marrow Donor Program, Minneapolis, MN, USA. Electronic address: kschoep2@nmdp.org.
⁵ National Marrow Donor Program, Minneapolis, MN, USA. Electronic address: jsees@nmdp.org.
⁶ National Marrow Donor Program, Minneapolis, MN, USA. Electronic address: aruffin@nmdp.org.
⁷ National Marrow Donor Program, Minneapolis, MN, USA. Electronic address: mmccann@nmdp.org.
⁸ National Marrow Donor Program, Minneapolis, MN, USA; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA. Electronic address: sdevine2@nmdp.org.
⁹ National Marrow Donor Program, Minneapolis, MN, USA; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA. Electronic address: jaulett3@nmdp.org.

PMID: 37353289
DOI: 10.1016/j.beha.2023.101480

Abstract

The treatment of malignant and nonmalignant hematologic disorders continues to benefit from significant scientific advancement and progress in the use of hematopoietic cell transplantation and cellular therapies. However, barriers associated with receiving these lifesaving treatments and care remain, which necessitate innovative approaches to overcome, so all persons in need can receive these therapies. This article reviews barriers to receiving hematopoietic cell transplantation and cellular therapies, and highlights novel approaches taken by the National Marrow Donor Program in reducing barriers for all patients in need.

Keywords: Access barriers; Cell therapy; Social determinants of health; Transplantation; Treatment barriers.

Publication types

Review

MeSH terms

Bone Marrow*
Hematopoietic Stem Cell Transplantation*
Humans